In November 2010, the FDA announced a recall of the drugs Darvon and Darvocet. Both are prescription painkiller drugs containing the active ingredient propoxyphene. Darvocet also contains acetaminophen, the active ingredient in Tylenol. The Darvon and Darvocet recall was initiated after the FDA determined that the benefits of these drugs do not outweigh the many risks associated with their consumption. Generic versions of the drug have been included in the recall as well.
Doctors have been instructed to stop prescribing the drugs at once, and patients taking Darvon and Darvocet should consult their healthcare professional about switching to an alternative medication.
Risks Associated with Darvon and Darvocet
Darvon first received FDA approval in 1957 for the treatment of mild to moderate post-surgical pain. Over the past 50 years, it has become one of the most widely prescribed medications in the country. Over 22 million people have taken Darvon and Darvocet to relieve pain following surgery.
For over 30 years, there has been considerable evidence that these drugs pose a danger to patients. In 1978, the consumer watch group Public Citizen petitioned the FDA to recall the drugs due to research indicating that Darvon and Darvocet were highly addictive, led to suicidal tendencies, and caused toxins to build up in the heart. Furthermore, data showed that propoxyphene was marginally more effective than acetaminophen alone in reducing pain among patients.
Over the past few decades, evidence continued to mount against Darvon and Darvocet. Propoxyphene has been associated with 2,110 reported accidental deaths since 1981. Many of these deaths occurred due to fatal heart rhythm abnormalities.
In 2005, Darvon and Darvocet were pulled from the market in the U.K. A year later, Public Citizen once again petitioned the FDA to recall the drugs. In 2008, the organization filed a lawsuit against the FDA for failing to act on their petition. In response to the lawsuit, the FDA's advisory panel conducted additional studies into the safety of Darvon and Darvocet. In January 2009, the advisory panel voted to recommend a recall of the drugs due to the strong evidence that they provided minimal benefit compared to their considerable health risks.
The FDA has finally acted on the recommendations of their advisory panel. Unfortunately, a more prompt response could have saved the lives of many patients.
Darvon and Darvocet Lawsuits
Currently, pharmaceutical injury lawyers across the country are accepting cases from families who have lost loved ones due to consumption of these drugs. If your loved one died from propoxyphene overdose, suicide, or heart-related conditions, you may be entitled to receive compensation through a wrongful death claim. It is important to consult an attorney at once since these cases are time-sensitive.
Please contact us today to find an experienced Darvon injury lawyer in your area.